LINDA VADERS: Open Payments
NPI 1811945041 · KETTERING, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,136 in 41 payments from 24 companies in 2025. Trend: 2023 $69 · 2024 $2,998 · 2025 $1,136
Food & beverage: $1,024Education: $112
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $143 |
| Amgen Inc. | 1 | $125 |
| Janssen Biotech, Inc. | 2 | $107 |
| ABBVIE INC. | 3 | $96 |
| Merck Sharp & Dohme LLC | 4 | $75 |
| Incyte Corporation | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
| Stemline Therapeutics Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
Products named: Enhertu, IMDELLTRA (AMG757), ERLEADA, KEYTRUDA, JAKAFI, VERZENIO, OPDIVO, OGSIVEO.
Industry payments across OH — which companies pay providers there.
